Prevalence of hepatitis C virus infection among prisoners in Iran: a systematic review and meta-analysis

被引:32
作者
Behzadifar, Masoud [1 ]
Gorji, Hasan Abolghasem [2 ]
Rezapour, Aziz [2 ]
Bragazzi, Nicola Luigi [3 ]
机构
[1] Iran Univ Med Sci, Sch Hlth Management & Informat Sci, Dept Hlth Serv Management, Tehran, Iran
[2] Iran Univ Med Sci, Hlth Management & Econ Res Ctr, Tehran, Iran
[3] Univ Genoa, Sch Publ Hlth, Dept Hlth Sci DISSAL, Genoa, Italy
关键词
Hepatitis C virus; Prevalence; Prisoners; Iran; Meta-analysis; Systematic review; INJECTION-DRUG USE; VIRAL-HEPATITIS; HARM REDUCTION; GLOBAL BURDEN; RISK-FACTORS; HIV; INMATES; COHORT; HCV; EPIDEMIOLOGY;
D O I
10.1186/s12954-018-0231-0
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Hepatitis C virus (HCV) is one of the major public health problems both in developed and developing countries. Prison represents a high-risk environment for prisoners, in that it is characterized by high-risk behaviors such as injecting drug use (IDU), tattooing, unprotected sexual intercourses, or sharing syringes. The aim of this study was to quantitatively evaluate the prevalence of HCV among Iranian prisoners conducting a systematic review and meta-analysis. Methods: We searched different scholarly databases including Embase, PubMed/MEDLINE, ISI/Web of Sciences, the Cochrane library, Scopus, CINAHL, and PsycINFO as well as Iranian bibliographic thesauri (namely, Barakatns, MagIran, and SID) up to December 2017. The Newcastle Ottawa Scale (NOS) was used to assess the quality of the studies included. HCV prevalence rate with its 95% confidence interval (CI) was estimated using the DerSimonian-Laird random-effects model, with Freeman-Tukey double arcsine transformation. Egger's regression test was used to evaluate publication bias. Results: Finally, 17 articles were selected based on inclusion and exclusion criteria. Overall, 18,693 prisoners were tested. Based on the random-effects model, the prevalence of HCV among Iranian prisoners was 28% (CI 95% 21-36) with heterogeneity of I-2 = 99.3% (p = 0.00). All studies used an ELISA test for the evaluation of HCV antibodies. The findings of this study showed that the highest prevalence rate (53%) was among prisoners who inject drugs. Conclusion: The findings of our study showed that the prevalence of HCV among Iranian prisoners is dramatically high. Managing this issue in Iran's prisons requires careful attention to the availability of health facilities and instruments, such as screening, and harm reduction policies, such as giving sterile syringes and needles to prisoners. An integrated program of training for prisoners, prison personnel and medical staff is also needed to improve the level of health condition in prisons.
引用
收藏
页数:9
相关论文
共 48 条
  • [31] Peña-Orellana M, 2011, J HEALTH CARE POOR U, V22, P962, DOI 10.1353/hpu.2011.0084
  • [32] Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Java']Javan prisons, Indonesia
    Prasetyo, Afiono Agung
    Dirgahayu, Paramasari
    Sari, Yulia
    Hudiyono, Hudiyono
    Kageyama, Seiji
    [J]. JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2013, 7 (06): : 453 - 467
  • [33] Transition to injecting drug use in Iran: A systematic review of qualitative and quantitative evidence
    Rahimi-Movaghar, Afarin
    Amin-Esmaeili, Masoumeh
    Shadloo, Behrang
    Noroozi, Alireza
    Malekinejad, Mohsen
    [J]. INTERNATIONAL JOURNAL OF DRUG POLICY, 2015, 26 (09) : 808 - 819
  • [34] Roshanfekr P, 2013, IRAN J PUBLIC HEALTH, V42, P1430
  • [35] Saberi Zafarghandi Mohammad Bagher, 2015, Int J High Risk Behav Addict, V4, pe22863, DOI 10.5812/ijhrba.22863
  • [36] Hepatitis C and B prevalence in Spanish prisons
    Saiz de la Hoya, P.
    Marco, A.
    Garcia-Guerrero, J.
    Rivera, A.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2011, 30 (07) : 857 - 862
  • [37] Overview of harm reduction in prisons in seven European countries
    Sander, Gen
    Scandurra, Alessio
    Kamenska, Anhelita
    MacNamara, Catherine
    Kalpaki, Christina
    Fernandez Bessa, Cristina
    Nicolas Laso, Gemma
    Parisi, Grazia
    Varley, Lorraine
    Wolny, Marcin
    Moudatsou, Maria
    Pontes, Nuno Henrique
    Mannix-McNamara, Patricia
    Libianchi, Sandro
    Antypas, Tzanetos
    [J]. HARM REDUCTION JOURNAL, 2016, 13
  • [38] Evidence-based consensus on the diagnosis, prevention and management of hepatitis C virus disease
    Shaheen, Mahrukh Akbar
    Idrees, Muhammad
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (03) : 616 - 627
  • [39] A Comparison of Liver Disease Mortality With HIV and Overdose Mortality Among Georgia Prisoners and Releasees: A 2-Decade Cohort Study of Prisoners Incarcerated in 1991
    Spaulding, Anne C.
    Sharma, Akshay
    Messina, Lauren C.
    Zlotorzynska, Maria
    Miller, Lesley
    Binswanger, Ingrid A.
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 2015, 105 (05) : E51 - E57
  • [40] Prisoner Survival Inside and Outside of the Institution: Implications for Health-Care Planning
    Spaulding, Anne C.
    Seals, Ryan M.
    McCallum, Victoria A.
    Perez, Sebastian D.
    Brzozowski, Amanda K.
    Steenland, N. Kyle
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 173 (05) : 479 - 487